Home > Boards > US Listed > Biotechs > Anavex Life Sciences Corp (AVXL)

Here is the GOOD and the BAD.

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (3) | Next 10 | Previous | Next
TempePhil Member Profile
 
Followed By 2
Posts 223
Boards Moderated 0
Alias Born 05/18/18
160x600 placeholder
Anavex Life Sciences Issued New U.S. Patent for ANAVEX®2-73 Treatment of Neurodevelopmental Disorders including Rett Syndrom... GlobeNewswire Inc. - 1/8/2020 7:00:10 AM
Anavex Life Sciences Reports Fiscal Year 2019 Financial Results And Provides Clinical Study Updates GlobeNewswire Inc. - 12/16/2019 7:00:10 AM
Anavex Life Sciences to Announce Fiscal 2019 Year End Financial Results on Monday December 16, 2019 GlobeNewswire Inc. - 12/10/2019 7:00:10 AM
Citation Growth Corp. (OTCQX: CGOTF) Weathering the Cannabis Downturn InvestorsHub NewsWire - 12/9/2019 7:23:11 AM
Anavex Life Sciences Presents ANAVEX®2-73 (blarcamesine) Data at 12th Clinical Trials on Alzheimer's Disease (CTAD) 2019 Con... GlobeNewswire Inc. - 12/4/2019 7:00:10 AM
Anavex Life Sciences Receives Rare Pediatric Disease Designation from FDA for ANAVEX®2-73 (blarcamesine) for the Treatment o... GlobeNewswire Inc. - 11/14/2019 7:00:00 AM
Anavex Life Sciences Announces Publication of Foundational Data for ANAVEX®2-73 (blarcamesine) in Rett Syndrome GlobeNewswire Inc. - 11/6/2019 7:00:00 AM
Anavex Life Sciences Announces ATTENTION-AD ANAVEX®2-73 Extension Clinical Study in Early Alzheimer’s Disease GlobeNewswire Inc. - 10/9/2019 7:00:00 AM
Anavex Life Sciences Issued New U.S. Patent for Composition of Matter Covering ANAVEX®2-73 for the Treatment of Alzheimer’... GlobeNewswire Inc. - 10/2/2019 7:00:00 AM
Anavex Life Sciences Presented at the 6th Annual European Rett Syndrome Conference Preliminary Clinical Efficacy Data from th... GlobeNewswire Inc. - 9/27/2019 3:00:00 AM
Anavex Life Sciences to Present at the 2019 Cantor Fitzgerald Global Healthcare Conference GlobeNewswire Inc. - 9/26/2019 7:00:00 AM
Notice of Effectiveness (effect) Edgar (US Regulatory) - 9/23/2019 6:35:19 AM
Anavex Life Sciences to Present at the Ladenburg Thalmann 2019 Healthcare Conference GlobeNewswire Inc. - 9/18/2019 7:00:00 AM
Post-effective Amendment to Registration Statement (pos Am) Edgar (US Regulatory) - 9/17/2019 5:16:10 PM
CLS Holdings (CLSH) $1.15 Price Target - MASS Approval for Recreational License InvestorsHub NewsWire - 9/17/2019 7:17:00 AM
Withdrawal of Registration Statement (ammendment) (aw) Edgar (US Regulatory) - 9/16/2019 4:17:42 PM
Anavex Life Sciences Announces Preliminary Clinical Efficacy Data of its U.S. Phase 2 Clinical Trial of ANAVEX®2-73 in Patie... GlobeNewswire Inc. - 9/16/2019 7:00:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 9/13/2019 5:11:08 PM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 9/13/2019 5:07:24 PM
Securities Registration Statement (simplified Form) (s-3/a) Edgar (US Regulatory) - 9/13/2019 5:02:44 PM
Anavex Life Sciences to Present at the Janney Healthcare Conference 2019 GlobeNewswire Inc. - 9/5/2019 7:00:00 AM
Anavex Life Sciences Announces Initiation of the EXCELLENCE ANAVEX®2-73-RS-003 Clinical Study in Pediatric Patients with Ret... GlobeNewswire Inc. - 9/4/2019 7:00:00 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 8/7/2019 4:07:28 PM
Anavex Life Sciences Reports Fiscal 2019 Third Quarter Financial Results And Provides Clinical Study Updates GlobeNewswire Inc. - 8/7/2019 7:00:00 AM
Anavex Life Sciences to Announce Fiscal 2019 Third Quarter Financial Results on Wednesday, August 7th, 2019 GlobeNewswire Inc. - 8/2/2019 7:00:00 AM
TempePhil   Thursday, 07/04/19 12:45:58 PM
Re: None
Post # of 231246 
Here is the GOOD and the BAD.
This shelf offering is consistent with what should be done, and with what Dr.M has said. Here is why.

THE GOOD
1) We have had enough money to fund the current trials and maintain THIS status quo. Consistent with what Dr.M has said. True. But Dr.M must see those days are coming to an end!

2) However, Anavex is about to move to the next stage, and needs more capital. Cant get a loan, no income, so sell stock, that is a major purpose of stock.
We cannot advance as a 20(?) employee company, with one financial person, no accounting dept, Dr.M going to ERP consortium meetings instead of an engineer, and a high school kid doing our website(maybesmile)
Seriously, we will need an accounts receivable group, a professional IT group, legal team, chemists, engineers, HR, a PR group and so on, just like the big boys. This shelf offering is because Dr.M realizes that in a few months we may be in the big leagues and need to be ready to play.

3) This offering has nothing to do with takeover, or partnership. Consistent with what Dr.M has said. The only partnership that Dr.M has been discussed is for distribution and MAYBE manufacturing. This is exactly the best path.
DISTRIBUTION: We do not have distribution networks, so we will need 'partners' for that. With positive AD results, we will be the most sought after company on earth. We will not need any partner, except as Dr.M has discussed. These arrangements are usually simple, the distributing company gets a percentage of their sales. They will balk at providing a bundle of money to Anavex for the privilege of working with us. We wont need it anyhow.
MANUFACTURING: As Dr.M has done, contracted out manufacturing of current drug 2-73. This is not a partnership, but could develop more.

4) This has nothing to do with buyout. Period.

THE BAD
1) Dilution. Yes this is dilution. But $250M hopefully can get us several steps closer to the $10B(?) company Dr.M has discussed. Then it will seem like a drop in the bucket.


In conclusion, if you believe Dr.M has been frugal, and a good manager, then this should be seen as good news, as he must see good news already, or expects it in the next 6 months.
If you think Dr.M is a liar, then you will see this as lifetime haircuts.

Also, I realize several MB contributors have come to some of these conclusions also. Hopefully, I have added to their contributions, and correlated their comments. I truly believe the MB collective wisdom is better for ALL the commentors, both positive and negative. And Xenas compiled DD is a great example of that.
Not trying to rival Bio here in length wink

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (3) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist